Company Number: 14027618

Analysis Date: 2025-07-29 14:45 UTC

1. Credit Opinion: DECLINE
   OTOLARYNGOBOT LIMITED is a micro-entity with minimal net assets (£76 in 2024, down from £113 in 2023) and negligible working capital. The company has no employees and very limited current assets barely exceeding current liabilities. Given the extremely thin balance sheet and absence of trading scale or cash reserves, the company lacks financial robustness to confidently service any meaningful debt or credit facility at this stage. The business appears to be in its infancy with no evidence of growing capital or strengthening liquidity. Without operational scale or retained earnings, the credit risk is high.

2. Financial Strength:
   The company’s balance sheet is very weak. Net assets and shareholders’ funds stand at just £76, indicating almost no equity cushion. Current assets of £3,557 slightly exceed current liabilities of £3,481, providing a marginal positive working capital of £76. This minimal buffer is insufficient to absorb any financial shocks or delays in receivables. No fixed assets or long-term investments are reported, and the business is wholly reliant on the director’s capital injection or external funding for operations.

3. Cash Flow Assessment:
   The micro-entity status and reported figures suggest minimal cash flow activity. The absence of employees and the low level of current assets imply limited operational cash inflows. The small net current asset position indicates very tight liquidity, with little headroom to cover unexpected expenses or short-term liabilities. There is no evidence of cash flow improvement or profitability to support debt repayment capacity.

4. Monitoring Points:

• Track growth in current assets and net assets to assess progress in building financial strength.
• Monitor cash flow statements and any trading activity to verify operational viability.
• Observe any changes in director funding or external financing that may improve liquidity.
• Watch for filed accounts in the next reporting period for signs of business development or further capital erosion.
• Verify that no adverse director conduct or legal issues arise, given the company's dependence on a single director.